Houston J Graeme, Bhat Raj, Ross Rose, Stonebridge Peter A
Clinical Radiology, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):42-7. doi: 10.1007/s00270-006-0111-y.
To retrospectively evaluate the 10 year follow-up results in patients who had "kissing" self-expanding stent aortic bifurcation reconstruction.
Forty-three patients were treated with "kissing" self-expanding stents for aortoiliac occlusive disease. Early follow-up with clinical and ankle brachial pressure indices (ABPI) was performed at 3, 6, 12, and 24 months and with intra-arterial digital subtraction angiography at 12-24 months; clinical and angiographic follow-up was performed for symptom recurrence up to 10 years after treatment. Retrospective record review was performed to assess mortality, clinical patency, angiographic patency, and secondary assisted patency of both stents and downstream peripheral vessels at 5 and 10 years follow-up.
The 2 year primary angiographic and secondary assisted stent patencies were 89% and 93%, respectively. At 10 years follow-up in 40 patients the mortality was 38% (due to myocardial infarction, stroke, chronic renal failure, malignancy, and liver failure). At 5 and 10 years follow-up the primary clinical stent patency was 82% and 68%, and the secondary assisted stent patency 93% and 86%, respectively. At 5 and 10 years, the distal vessel patency was 86% and 72%, and the secondary assisted distal vessel patency treated by surgical or endovascular techniques was 94% and 88%, respectively. At 10 years there was no limb loss.
The long-term (10 year) results of aortic bifurcation arterial self-expanding stent placement in patients with arterial occlusive disease show a 10 year primary stent patency rate of 68% but a secondary assisted patency rate of 86%. In addition there is a high overall mortality due to other cardiovascular causes and the rate of distal disease progression and loss of patency is similar to the loss of stent patency rate.
回顾性评估接受“亲吻”自膨式支架主动脉分叉重建术患者的10年随访结果。
43例患有主髂动脉闭塞性疾病的患者接受了“亲吻”自膨式支架治疗。在3、6、12和24个月时进行早期临床随访及踝肱压力指数(ABPI)测量,并在12 - 24个月时进行动脉数字减影血管造影;对治疗后长达10年的症状复发情况进行临床和血管造影随访。进行回顾性记录审查,以评估5年和10年随访时的死亡率、临床通畅率、血管造影通畅率以及支架和下游外周血管的二次辅助通畅率。
2年时主要血管造影和二次辅助支架通畅率分别为89%和93%。40例患者在10年随访时死亡率为38%(原因包括心肌梗死、中风、慢性肾衰竭、恶性肿瘤和肝衰竭)。在5年和10年随访时,主要临床支架通畅率分别为82%和68%,二次辅助支架通畅率分别为93%和86%。在5年和10年时,远端血管通畅率分别为86%和72%,通过手术或血管内技术治疗的二次辅助远端血管通畅率分别为94%和88%。10年时无肢体缺失。
动脉闭塞性疾病患者主动脉分叉动脉自膨式支架置入的长期(10年)结果显示,10年主要支架通畅率为68%,但二次辅助通畅率为86%。此外,由于其他心血管原因导致的总体死亡率较高,远端疾病进展和通畅丧失率与支架通畅丧失率相似。